Babak Nazer

My research focuses on medical device innovation and development in small and large animal models, and has progressed to first-in-human studies and a start-up company with multiple NIH SBIR grants and private funding. In fall of 2022, I moved my clinical program (which focuses on the intersection of arrhythmias—specifically ventricular tachycardia—and cardiomyopathies) and research programs to University of Washington in part to gain access to a broader array of basic science and engineering collaborators with which to execute a broader array of medical device collaborations. My laboratory designs, fabricates, validates and tests therapeutic ultrasound devices for various cardiovascular applications, including hypertrophic cardiomyopathy and ventricular tachycardia ablation. We also collaborate with other laboratories at UW and medical device incubators and companies on other medical device projects, including piezoelectric energy harvesting pacemakers and optical devices for colon cancer detection. Finally, we collaborate on translational studies on the arrhythmic risks of tetralogy of Fallot, cardiac sarcoidosis and genetic cardiomyopathies.